我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
隶属于 MERCK KGAA
相关临床试验
21
19 进行中
药物批准
3
批准总数
监管机构
1
监管机构数
成立时间
N/A
进行中（未招募）
19
90.5%
已完成
2
9.5%
PHILIPPINES
Philippines FDA
- The Federal Circuit upheld a Patent Trial and Appeal Board decision invalidating a Merck KGaA unit's patent for a multiple sclerosis drug. - Senior Judge Richard Linn issued a precedential opinion clarifying interpretation of "by others" and "by another" phrases in pre-2011 Patent Act obviousness determinations. - Hopewell Pharma Ventures Inc. successfully challenged the patent technology as obvious in January 2023 proceedings. - The ruling reinforces the court's precedential interpretation of key Patent Act language affecting pharmaceutical patent validity assessments.
